6533b829fe1ef96bd1289955
RESEARCH PRODUCT
Treatment and outcome(s) of a large cohort of Italian patients (pts) with poor-risk metastatic renal cell carcinoma (prRCC)
Michele De TursiMatteo SantoniFrancesco MassariLisa DerosaGiuseppe Di LorenzoEnrico CortesiIsabella SperdutiMichele MilellaGaetano FacchiniGiuseppe BadalamentiAlessandra FeliciFlavia LongoDaniele SantiniUgo De GiorgiPaolo MarchettiLaura NotoMarco MaruzzoJoan CarlesFrancesco Maria GuidaElena Verzonisubject
OncologyCancer Researchmedicine.medical_specialtyPoor riskbusiness.industrymedicine.diseaseTemsirolimusLarge cohortSurgeryOncologyRenal cell carcinomaInternal medicinemedicinebusinessmedicine.drugdescription
e15568 Background: With the exception of the Temsirolimus (Tem) registration trial, prRCC pts are grossly underrepresented in trials that have evaluated different therapeutic strategies. Methods: W...
year | journal | country | edition | language |
---|---|---|---|---|
2014-05-20 |